Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01922297 · ClinicalTrials.gov registry record · NA
Juvenile Offender HIV Prevention and Drug Abuse Services
A NA study of Substance Abuse and Risk Behavior, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT01922297: Completed NA study of Substance Abuse and Risk Behavior, sponsored by University of Miami.
NCT01922297 is a NA study of Substance Abuse and Risk Behavior that has completed, run by University of Miami. The registered enrollment target is 121 participants, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01922297, a NA study of Substance Abuse and Risk Behavior, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the clinical effectiveness, moderators and mechanisms of change, and economic impact of an integrative, family-based intervention that concurrently targets change in HIV/Sexually Transmitted Disease (STD)-associated risk behaviors, drug abuse, delinquency, arrest and mental health outcomes for juvenile offenders committed to a juvenile justice day treatment program.
Primary Outcome
The Timeline Follow-Back Method, Personal Experiences Inventory and Urinalyses will be used to measure substance use
Conditions Studied
Interventions
- OTHER Day Treatment MDFT-HIV
- OTHER Day Treatment SAU
Study Locations (1)
Florida
- University of Miami Miller School of Medicine - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01922297 record still lists
NCT01922297 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Day Treatment MDFT-HIV is the first listed.
NCT01922297 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01922297 about?
NCT01922297 is a clinical study titled "Juvenile Offender HIV Prevention and Drug Abuse Services". This study will determine the clinical effectiveness, moderators and mechanisms of change, and economic impact of an integrative, family-based intervention that concurrently targets change in HIV/Sexually Transmitted Disease (STD)-associated risk behaviors, drug abuse, delinquency, arrest and mental...
What is the current status of trial NCT01922297?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2010-01. Estimated completion is 2015-04.
What conditions does trial NCT01922297 study?
This clinical trial studies the following conditions: Substance Abuse, Risk Behavior, Delinquency.
What interventions are being tested in trial NCT01922297?
The interventions under investigation include: Day Treatment MDFT-HIV (OTHER), Day Treatment SAU (OTHER).
Who is sponsoring clinical trial NCT01922297?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01922297 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01922297's enrollment target sits among peer trials
121 34th of 58 higher than 25 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia